A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-516743-34-00

Acronym

TAK-079-1006

Enrollment

Registered

2024-10-14

Start date

2022-07-25

Completion date

2025-03-25

Last updated

2025-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IgAN is Primary Immunoglobulin A Nephropathy (IgAN) (also known as Berger's disease)

None listed

Sex/Gender

All

Age

18 Years to No maximum

Hungary, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026